Equity Capital And Reserves Alterar Data
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amgen USD 6.23B 1.42B 2023-12
Arrowhead Research USD 160.41M 110.94M 2023-12
Avrobio USD 102.86M 19.18M 2023-09
BioCryst Pharmaceuticals USD -410986000 22.27M 2023-09
BioMarin Pharmaceutical USD 4.95B 54.65M 2023-12
Bluebird Bio USD 222.54M 66.48M 2023-09
Incyte USD 5.19B 258.39M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Moderna USD 13.85B 399M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
PTC Therapeutics USD -818555000 147.74M 2023-12
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Regulus Therapeutics USD 28.26M 5.74M 2023-09
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Takeda JPY 7.07T 149.3B 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09
Xencor USD 668.8M 214K 2023-12



Alnylam Pharmaceuticals Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.